Name
CLINICAL PARALLEL 4 - Optimizing HBV Treatment: Prospects for a functional cure
Date & Time
Wednesday, March 19, 2025, 3:30 PM - 5:00 PM
Speakers
Adam Gehring, University Health Network
Kosh Agarwal, Kings College Hospital
Anna Coutinho, GSK
Fabien Zoulim, Lyon University
Lisa van Velsen, Erasmus University Medical Center
Kosh Agarwal, Kings College Hospital
Anna Coutinho, GSK
Fabien Zoulim, Lyon University
Lisa van Velsen, Erasmus University Medical Center
Description
- Progress towards a Sterilizing Cure - Advances in Gene editing and Targeting cccDNA Fabien Zoulim
- The Role of RNA interference (siRNA, ASO) as the backbone of HBV Cure strategies Kosh Agarwal
- Therapeutic Vaccines and Other Immune Targets for Functional Cure, How Good is the Promise? Adam Gehring
- Oral Presentation: ASSOCIATION OF HEPATITIS B SURFACE ANTIGEN LOSS WITH CLINICAL OUTCOMES AMONG PATIENTS WITH CHRONIC HEPATITIS B INFECTION: A RETROSPECTIVE COHORT STUDY IN THE UNITED STATES Anna Coutinho
- Oral Presentation: TREATMENT RELATED NORMALIZATION OF ALT IS ASSOCIATED WITH RESOLUTION OF SIGNIFICANT LIVER INFLAMMATION IN PATIENTS WITH CHRONIC HEPATITIS B Lisa van Velsen
- Q&A